欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NO/H/0241/002
药品名称
Risedronat Orifarm
活性成分
risedronate sodium salt 30.0 mg
剂型
Film-coated tablet
上市许可持有人
Orifarm Generics A/S Energivej 15 5260 Odense C Denmark
参考成员国 - 产品名称
Norway (NO)
互认成员国 - 产品名称
许可日期
2013/01/04
最近更新日期
2013/11/19
药物ATC编码
M05BA07 risedronic acid
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common_pl_30mgclean
Date of last change:2024/09/06
Final PL
|
common_pl_30mgtrackchanges
Date of last change:2024/09/06
Final PL
|
common_pl_35mclean
Date of last change:2024/09/06
Final PL
|
common_pl_35mgtrackchanges
Date of last change:2024/09/06
Final PL
|
common_pl_5mgclean
Date of last change:2024/09/06
Final PL
|
common_pl_5mgtrackchanges
Date of last change:2024/09/06
Final SPC
|
common_spc_30mgclean
Date of last change:2024/09/06
Final SPC
|
common_spc_30mgtrackchanges
Date of last change:2024/09/06
Final SPC
|
common_spc_35mgclean
Date of last change:2024/09/06
Final SPC
|
common_spc_35mgtrackchanges
Date of last change:2024/09/06
Final SPC
|
common_spc_5mgclean
Date of last change:2024/09/06
Final SPC
|
common_spc_5mgtrackchanges
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase